8-Puff Dry-Powder Inhaler Wins Red Dot Product Design Award

Hovione Technology’s 8Shot Dry Powder Inhaler (DPI) has earned the Red Dot 2020 Product Design Award in the Healthcare Daily Living AIDS category. João Ventura Fernandes, PhD, director of technology development and licensing for Hovione Technology Ltd., told MD+DI that 8Shot “was developed to be the world’s first 8-dose, factory-filled dry powder inhaler device enabling effective and safe drug delivery to the lungs of a range of drugs expected to be developed and reach the market during the next years." It is targeted for "delivery of new pharmaceutical compounds requiring very high doses, such as inhaled biologics, antibiotics, anti-virals, vaccines, pain, or rescue drugs for life-threatening conditions,” he said. Fernandes explained that the “need for high-dose drug delivery to the lungs is emerging outside the established asthma and COPD drug pipeline, which have typically required the delivery of small drug amounts, in the order of 0.2 to 0.5 mg of therapeutic doses to patients by the current inhaler device technologies. In fact, many new drugs in development to treat patients with serious, life-threatening lung diseases such as lung infections—such as those arising from pneumonia—cystic fibrosis (CF), pulmonary arterial hypertension (PAH), idiopathic pulmonary fibrosis (IPF), or lung cancer are much less potent and thus require del...
Source: MDDI - Category: Medical Devices Authors: Tags: Design Source Type: news